Elisa Agostinetto and Giuseppe Curigliano discuss the results of Destiny-Breast06
Elisa Agostinetto shared on LinkedIn:
“At ASCO24 I met Prof Giuseppe Curigliano to discuss the results of Destiny-Breast06 on T-DXd in HER2-low and ultra low breast cancer
We discussed implications for clinical practice, future perspectives and tips to manage ILD.”.
Read further
Source: Elisa Agostinetto/LinkedIn
Dr. Elisa Agostinetto, is a medical oncologist, specializing in breast cancer research. Trained in Milan, Italy, she currently conducts advanced research at Institut Jules Bordet – Université Libre de Bruxelles in Brussels, Belgium. Actively engaged in professional societies like ESMO, ASCO, and BSMO, she also contributes as a young investigator in the EORTC Breast Cancer Working Group and as a Committee member of the Young Cancer Professionals within the European Cancer Organization.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023